Sponsored Research Agreement. The terms of Section 5.3 of that certain amended Sponsored Research Agreement dated as of September 18, 2013 by and between Wistar and Company (the “SRA”), shall remain in effect as long as the SRA remains in effect.
Sponsored Research Agreement. Kite, The Medical Research, Infrastructure, and Health Services Fund of the Tel Aviv Medical Center shall execute a mutually acceptable sponsored research agreement, pursuant to which such institution shall conduct research, according to a mutually agreed research workplan, to be funded by Kite according to a mutually agreed budget of at least US$60,000 per year, according to a mutually agreed funding schedule for a period of not less than three (3) years on the terms and conditions thereof.
Sponsored Research Agreement. This agreement may be used where a company will contribute financial or in-kind support for research to be undertaken by a university or research organisation.
Sponsored Research Agreement. This template is suitable for a sponsored research relationship between a university (or other research organisation) and a company, where the company will contribute financial or in-kind support for research performed by the university or research organization. Most universities expect to own all Project IP resulting from university research despite a company’s funding. In some countries, this is mandated by law, but in most countries, it is a matter of university policy. Even in countries where professor privilege applies, ownership of Project IP is generally decided between the university and the professor and is not conveyed to company sponsors of research. The company that provides financial or in-kind support for university research will negotiate for some preferential right of access to the Project IP, most likely in the form of a royalty-bearing license. The company may wish to negotiate a license at the time of funding, but most universities and research organizations are reluctant to commit to license terms in advance. Without knowing what the Project IP might be, neither party to a sponsored research agreement can accurately predict its value, and, therefore, the parties are unable to negotiate royalty and other terms. The university or research organization, in consideration for the funding, may grant the company an option for a royalty-bearing license which can be exercised by the company during a defined period after the research is concluded (Option Period). In most cases, the option is for an exclusive license under any Project IP resulting from the sponsored research. The option provision in the sponsored research agreement should also specify the time after exercise of the option during which the parties are obligated to negotiate (Negotiation Period). The company may also negotiate for confidentiality in relation to the Project IP. It is appropriate for the university or research organization to agree to a limited period of confidentiality to permit filing for patent protection before disclosure prevents obtaining that protection. For the same reason, the company will wish to prevent publication of Project IP until the university can file for patent protection.
Sponsored Research Agreement. Arizona State University EXHIBIT B PURE AIR TECHNOLOGIES, INC. Financial Statements as of October , 2006 EXHIBIT C World Energy Solutions, Inc. FORM 10-QSB QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2006. Initials EXHIBIT D World Energy Solutions, Inc. IRREVOCABLE TRANSFER AGENT INSTRUCTIONS Initials (EXHIBIT A – 1) Agreement No. STANDARD EXCLUSIVE LICENSE AGREEMENT WITH SUBLICENSING TERMS TABLE OF CONTENTS Section 1 Definitions Section 2 Grant Section 3 Due Diligence Section 4 Payments Section 5 Certain Warranties and Disclaimers of UFRF
Sponsored Research Agreement. The milestones for Phase I are provided in Table 1. These milestones are all aimed at laboratory scale testing and refinement of the CAPOS system by the CAPOS university team. Note that a total time period of 24 months is anticipated for Phase 1, with Milestone 1.4 occurring simultaneously with Milestone 1.3. Each milestone is described in subsequent sections. Table 1: Summary of Phase 1 Milestones Milestone Number Description Duration (Months)
Sponsored Research Agreement. Upon its execution, a copy of the executed Sponsored Research Agreement by and between Lion and KI will be attached hereto. SCHEDULE 7
Sponsored Research Agreement. Separately and independent of the contemplated license agreement, the parties will enter into a sponsored research agreement pursuant to which Licensee will fund research at Imperial Innovations Limited and/or CRT in an amount to be agreed and for a term to be agreed, which research scope and related terms, including IP rights arising from the funded research, will be negotiated in good faith between the parties after the Effective Date.
Sponsored Research Agreement. After the Closing, Parent and Purdue University will negotiate in good faith to enter into a Sponsored Research Agreement, by and among, Parent and Purdue University, on reasonably customary terms and otherwise substantially consistent with the existing form of Purdue Sponsored Research Agreement; provided that such agreement will have an initial term of not more than two years and an obligation to fund not more than $250,000 per year.
Sponsored Research Agreement. Licensee agrees to provide, under a separate sponsored research agreement, funding for research in mutually-agreed fields conducted in Xx. Xxxxx Xxxxxxxxxx’s laboratory in an amount of at least Two Hundred Thousand U.S. Dollars ($200,000) per year for three (3) years, commencing in January 2016. Licensee will get a time-limited, free option to obtain a world-wide exclusive license upon commercially reasonable terms for any new inventions or improvements on existing inventions that result from this research. The term of the option shall be [*] after disclosure of the invention to Licensee by MSK. The Parties agree that as of the Effective Date, Licensee’s payment obligations under this Section 5.5 with respect to 2016 have been fulfilled.
